Clinical Trial Update: A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients

View source ↗

Summary

Pfizer-sponsored study explored using 18FDG PET imaging to monitor the effectiveness of new COPD drugs, but the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Disease, Chronic Obstructive | Status: TERMINATED